Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular endothelial dysfunction

G R De Meyer1, A G Herman

  • 1Division of Pharmacology, University of Antwerp (UIA), Wilrijk, Belgium.

Progress in Cardiovascular Diseases
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.

Acta clinica Belgica·2010
Same author

Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells.

British journal of pharmacology·2009
Same author

Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

British journal of pharmacology·2008
Same author

TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats.

The Journal of physiology·2008
Same author

Lessons from ONTARGET.

Acta clinica Belgica·2008
Same author

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.

Neurogastroenterology and motility·2008
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Endothelial dysfunction, an imbalance in vascular factors, contributes to diseases like hypercholesterolemia and atherosclerosis. Understanding these mechanisms is key to developing therapeutic approaches for dysfunctional endothelium.

Area of Science:

  • Cardiovascular Science
  • Cell Biology
  • Pathophysiology

Background:

  • Endothelial cells regulate vascular function through a balance of factors.
  • Dysfunction arises from imbalances in relaxing/contracting factors, procoagulant/anticoagulant mediators, and growth regulators.
  • Abnormal endothelial cell function follows injury or activation.

Purpose of the Study:

  • To review endothelial dysfunction in hypercholesterolemia and atherosclerosis.
  • To explore the role of nitric oxide, endothelin, and other mediators.
  • To discuss endothelial dysfunction in hypertension, syndrome X, and diabetes.
  • To provide an overview of therapeutic strategies.

Main Methods:

  • Literature review focusing on endothelial dysfunction.

Related Experiment Videos

  • Analysis of mechanisms in hypercholesterolemia and atherosclerosis.
  • Examination of endothelial dysfunction in other pathologies.
  • Synthesis of therapeutic approaches.

    • Main Results:

    • Endothelial dysfunction is characterized by an imbalance of vasoactive, thrombotic, and growth factors.
    • Specific mediators like nitric oxide, endothelin, cytokines, and adhesion molecules are implicated.
    • Conditions such as hypercholesterolemia, atherosclerosis, hypertension, and diabetes exhibit endothelial dysfunction.
    • Therapeutic interventions aim to restore endothelial function.

    Conclusions:

    • Endothelial dysfunction is a central mechanism in various cardiovascular diseases.
    • Targeting specific molecular pathways offers potential therapeutic benefits.
    • Restoring endothelial balance is crucial for managing vascular health.